World Drug Safety Congress Europe 2019 - 10 and 11 September - Amsterdam

Memo

Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions. WORLD DRUG SAFETY FOCUSES ON:How to plan for the wider international drug safety landscape How to work compliantly with a global regulatory overview and recent developmentsHow to establish a robust approach to safety in oncology and advanced therapiesHow to harness Big Data and emerging technologies such as AI to support your safety measures How to manage drug safety operations in light of increasing complexities How to manage data and electronic submissions better How to effectively process the volume of cases How to operate within financial and logistical constraints All companies in the pharma industry have an enormous opportunity to better their drug safety capabilities, technological functions and risk management measures. It is core to ensuring regulatory compliance and establishing a robust PV strategy. It is core to your professional future. URLs: Tickets: https://go.evvnt.com/305573-0?pid=5569Twitter: https://go.evvnt.com/305573-2?pid=5569 Prices:STANDARD PACKAGE: EUR 1350.0,PHARMA BIOTECH PACKAGE: EUR 950.0,ACADEMIC and REGULATORY PACKAGE: EUR 400.0. Speakers: Doris Stenver, David Chonzi, Jackie Roberts, Matthias Boedding, Heike Schoepper, Catherine Cohet, Pedro Lima, Celine Adessi, Steinar Madsen, Jabeen Ahmad, Fernando Solimando, Attila Oláh, Christelle Boeynaems, Elena Davison, Raj Bhogal, John Solomon, Haris Shaikh, Andrea Best, Amgad Shebl, Sutirtha Mukhopadhyay, Salvatore Giorgio Cicirello, Ricarda Tiemeyer, Nicole Baker, Heinz Weidenthaler, Sergiy Kryvych. Time: 9:00 am to 6:00 pm. Venue details: Hilton Amsterdam, 138 Apollolaan, Amsterdam, 1077 BG, Netherlands.